{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2016"],"condition":["comorbidity","colorectal cancer","Cancer-Bowel-Back passage (rectum) or large bowel (colon)"],"disease":["Comorbidity","Colorectal Cancer","Cancer-bowel-back Passage (rectum) Or Large Bowel (colon)"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2462983"],"location":["New Zealand"],"study_start_month":["1"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"A feasibility study: Improving management of comorbidity in patients with colorectal cancer","description":"Primary outcome(s): Proportion of patients with colorectal adenocarcinoma who are approached who consent to enter.\nThis outcome will be assessed by use of a screening log, this will capture all those who are approached and whether they consented to proceed.[At one year after enrolment of first eligible patient];Proportion of patients who consent to enter whom complete screening criterial and fulfil criteria to proceed to CMA\nThis outcome will be assessed by use of a screening log, whether or not a subject proceeds to CMA will be captured as part of the screening log.[one year from enrolment of first eligible patient];Narrative of comorbid conditions identified at CMA[one year from enrolment of first eligible patient]\nStudy Design: Purpose: Treatment; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Single group","dates":{"creation":"2016-01-15"},"accession":"2462983","cross_references":{"Australian New Zealand Clinical Trials Registry":["ACTRN12615001312538"]}}